1. Home
  2. CORT vs TPG Comparison

CORT vs TPG Comparison

Compare CORT & TPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • TPG
  • Stock Information
  • Founded
  • CORT 1998
  • TPG 1992
  • Country
  • CORT United States
  • TPG United States
  • Employees
  • CORT N/A
  • TPG N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • TPG Investment Managers
  • Sector
  • CORT Health Care
  • TPG Finance
  • Exchange
  • CORT Nasdaq
  • TPG Nasdaq
  • Market Cap
  • CORT 7.5B
  • TPG 6.2B
  • IPO Year
  • CORT N/A
  • TPG 2022
  • Fundamental
  • Price
  • CORT $72.98
  • TPG $54.07
  • Analyst Decision
  • CORT Strong Buy
  • TPG Buy
  • Analyst Count
  • CORT 4
  • TPG 13
  • Target Price
  • CORT $142.00
  • TPG $62.17
  • AVG Volume (30 Days)
  • CORT 1.6M
  • TPG 1.8M
  • Earning Date
  • CORT 07-28-2025
  • TPG 08-05-2025
  • Dividend Yield
  • CORT N/A
  • TPG 3.22%
  • EPS Growth
  • CORT 8.36
  • TPG N/A
  • EPS
  • CORT 1.14
  • TPG N/A
  • Revenue
  • CORT $685,446,000.00
  • TPG $3,710,887,000.00
  • Revenue This Year
  • CORT $35.83
  • TPG N/A
  • Revenue Next Year
  • CORT $35.24
  • TPG $23.44
  • P/E Ratio
  • CORT $63.26
  • TPG $17,462.27
  • Revenue Growth
  • CORT 30.93
  • TPG 44.34
  • 52 Week Low
  • CORT $29.42
  • TPG $37.52
  • 52 Week High
  • CORT $117.33
  • TPG $72.98
  • Technical
  • Relative Strength Index (RSI)
  • CORT 49.68
  • TPG 66.49
  • Support Level
  • CORT $68.52
  • TPG $51.83
  • Resistance Level
  • CORT $75.95
  • TPG $54.27
  • Average True Range (ATR)
  • CORT 2.66
  • TPG 1.47
  • MACD
  • CORT -0.13
  • TPG 0.26
  • Stochastic Oscillator
  • CORT 42.13
  • TPG 88.67

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About TPG TPG Inc.

TPG Inc is an alternative asset management firm. It invests across five multi-product platforms namely Capital, Growth, Impact, Real Estate, Market Solutions, and TPG Angelo Gordon. The company focuses on large-scale, control-oriented private equity investments.

Share on Social Networks: